NDC 68220-086

PreferaOB One

Folic Acid, Heme Iron Polypeptide, Iron Dextran, Potassium Iodide, Zinc Oxide, Ascorbic Acid, Cholecalciferol, Doconexent, .alpha.-tocopherol Acetate, Dl-, Niacinamide, Pyridoxine Hydrochloride, Cyano

PreferaOB One is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Alaven Pharmaceutical Llc. The primary component is Folic Acid; Heme Iron Polypeptide; Iron Dextran; Potassium Iodide; Zinc Oxide; Ascorbic Acid; Cholecalciferol; Doconexent; .alpha.-tocopherol Acetate, Dl-; Niacinamide; Pyridoxine Hydrochloride; Cyanocobalamin; Biotin; Calcium Pantothenate.

Product ID68220-086_69e082a6-77dd-46e0-b3eb-90bb6d167b82
NDC68220-086
Product TypeHuman Prescription Drug
Proprietary NamePreferaOB One
Generic NameFolic Acid, Heme Iron Polypeptide, Iron Dextran, Potassium Iodide, Zinc Oxide, Ascorbic Acid, Cholecalciferol, Doconexent, .alpha.-tocopherol Acetate, Dl-, Niacinamide, Pyridoxine Hydrochloride, Cyano
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2010-04-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAlaven Pharmaceutical LLC
Substance NameFOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; POTASSIUM IODIDE; ZINC OXIDE; ASCORBIC ACID; CHOLECALCIFEROL; DOCONEXENT; .ALPHA.-TOCOPHEROL ACETATE, DL-; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE
Active Ingredient Strength1 mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; ug/1; ug/1; mg/1
Pharm ClassesPotassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 68220-086-25

1 BLISTER PACK in 1 CARTON (68220-086-25) > 5 CAPSULE in 1 BLISTER PACK (68220-086-05)
Marketing Start Date2010-04-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68220-086-30 [68220008630]

PreferaOB One CAPSULE
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-04-01
Marketing End Date2019-01-01
Inactivation Date2019-10-21
Reactivation Date2020-02-04

NDC 68220-086-05 [68220008605]

PreferaOB One CAPSULE
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Marketing End Date2019-01-01

NDC 68220-086-25 [68220008625]

PreferaOB One CAPSULE
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Marketing End Date2019-01-01
Inactivation Date2019-10-21
Reactivation Date2020-02-04

Drug Details

Active Ingredients

IngredientStrength
FOLIC ACID1 mg/1

OpenFDA Data

SPL SET ID:db9fede8-b6d5-40a9-84cb-f928553f8e6c
Manufacturer
UNII

Pharmacological Class

  • Potassium Compounds [CS]
  • Potassium Salt [EPC]
  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Vitamin C [EPC]
  • Ascorbic Acid [CS]
  • Vitamin D [CS]
  • Vitamin D [EPC]
  • Vitamin B6 Analog [EPC]
  • Vitamin B 6 [Chemical/Ingredient]
  • Analogs/Derivatives [Chemical/Ingredient]
  • Vitamin B 12 [CS]
  • Vitamin B12 [EPC]

Medicade Reported Pricing

68220008630 PREFERA-OB ONE SOFTGEL

Pricing Unit: EA | Drug Type:

Trademark Results [PreferaOB One]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PREFERAOB ONE
PREFERAOB ONE
85055113 3864658 Dead/Cancelled
Alaven Pharmaceutical LLC
2010-06-04
PREFERAOB ONE
PREFERAOB ONE
85055096 3864657 Dead/Cancelled
Alaven Pharmaceutical LLC
2010-06-04
PREFERAOB ONE
PREFERAOB ONE
85055082 3864656 Live/Registered
Alaven Pharmaceutical LLC
2010-06-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.